About the job
Join Axsome Therapeutics, a pioneering biopharmaceutical company that is redefining the landscape of central nervous system (CNS) therapies. We are committed to bridging critical gaps in healthcare by developing innovative products focused on unique mechanisms of action that lead to significant improvements in patient outcomes. Our cutting-edge neuroscience portfolio features FDA-approved solutions for major depressive disorder, excessive daytime sleepiness related to narcolepsy and obstructive sleep apnea, as well as migraine, alongside multiple late-stage development initiatives targeting a wide array of serious neurological and psychiatric disorders affecting over 150 million individuals across the United States. Together, we aim to tackle some of the most pressing challenges in brain health, enabling patients and their families to thrive. For further details, visit us at www.axsome.com and connect with us on LinkedIn.

